COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,031 Cr | ₹2,254 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr |
What is the latest Total Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,031 Cr |
| Mar2024 | ₹2,254 Cr |
| Mar2023 | ₹2,110 Cr |
| Mar2022 | ₹1,967 Cr |
| Mar2021 | ₹1,576 Cr |
How is Total Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,031 Cr | 34.47 | |
| Mar2024 | ₹2,254 Cr | 6.83 | |
| Mar2023 | ₹2,110 Cr | 7.28 | |
| Mar2022 | ₹1,967 Cr | 24.78 | |
| Mar2021 | ₹1,576 Cr | - | |
Compare Total Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,276.3 Cr | -0.3% | 4.8% | -56.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -0.3% |
4.8% |
-56.2% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses